Bottom line
VHT vs HCPIX: the short answer
VHT (Vanguard Health Care Index Fund) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 72% by weight.
But VHT is far broader, holding 407 positions to 69 for HCPIX, so beyond the top names it adds exposure HCPIX doesn't have.
VHT is cheaper at 0.09% vs 1.76% — a difference of $167 a year per $10,000 invested.
Over five years, VHT returned +7.2% a year vs +6.4% for HCPIX.
Updated Nov 19, 2026
VHT vs HCPIX side by side
| VHT | HCPIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Vanguard | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 1.76% |
| Annual cost per $10k | $9 | $176 |
| 10-yr cost on $10k (prospectus) | $115 | $2,073 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +2.7% | −1.4% |
| 5-yr return (annualized) | +7.2% | +6.4% |
| 10-yr return (annualized) | +8.8% | +9.2% |
| Best quarter | +16.5% | +22.0% |
| Worst quarter | −13.1% | −21.0% |
| Net assets (fund) | $19.0B | $12.1M |
| Number of holdings | 407 | 69 |
| Portfolio turnover | 4% | 99% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VHT | HCPIX | Difference |
|---|---|---|---|
| 2024 | +2.7% | −1.4% | +4.0% |
| 2023 | +2.5% | −1.3% | +3.8% |
| 2022 | −5.5% | −10.6% | +5.1% |
| 2021 | +20.5% | +33.9% | −13.4% |
| 2020 | +18.2% | +16.9% | +1.4% |
| 2019 | +22.0% | +28.4% | −6.5% |
| 2018 | +5.6% | +5.0% | +0.6% |
| 2017 | +23.3% | +32.2% | −8.8% |
| 2016 | −3.3% | −6.5% | +3.2% |
| 2015 | +7.2% | +6.4% | +0.8% |
Source: Fund prospectus bar charts
Holdings overlap
19 of VHT's top 25 holdings also appear in HCPIX's top 25.
| Holding | VHT | HCPIX |
|---|---|---|
| Eli Lilly & Co | 14.04% | 11.83% |
| Johnson & Johnson | 8.47% | 8.03% |
| AbbVie Inc | 6.09% | 5.77% |
| UnitedHealth Group Inc | 5.45% | 4.90% |
| Merck & Co Inc | 4.66% | 4.19% |
| Thermo Fisher Scientific Inc | 2.93% | 2.78% |
| Amgen Inc | 2.87% | 2.71% |
| Gilead Sciences Inc | 2.64% | 2.10% |
| Intuitive Surgical Inc | 2.38% | 1.63% |
| Pfizer Inc | 2.35% | 1.86% |
| Abbott Laboratories | 2.35% | 2.40% |
| Bristol-Myers Squibb Co | 1.84% | 1.74% |
| Danaher Corp | 1.84% | 1.60% |
| CVS Health Corp | 1.83% | 1.73% |
| Vertex Pharmaceuticals Inc | 1.80% | 1.57% |
Source: SEC Form N-PORT
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FAQ
What is the difference between VHT and HCPIX?
Which is cheaper, VHT or HCPIX?
Should I own both VHT and HCPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.